Hiebert-Suwondo L. . ."A 2024 global report on national policy, programs, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles.". The Lancet Gastroenterology & Hepatology, 10(2025) : 671-684.
Health Organization. "Hepatitis World,B: key facts. World .2025 .. , : .
Madihi S. . ."Advancing hepatitis B elimination: a systematic review of global immunization progress and future directions." Diagnostic Microbiology and Infectious Disease. , 111(2025) : 116666.
Lindstrand A. .2021 ."The world of immunization: achievements, challenges, and strategic vision for the next decade.". The Journal of Infectious Diseases, 224(Suppl 2) : S452-S467.
Delghandi S. .2024 ."An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination.". Heliyon, 10(17) : e37097.
Hudu S.A. .2013 ."Occult hepatitis B infection among vaccinated cohort. " Journal of Viral Hepatitis, 20(Suppl 1) : 30.
Awaidy Al,S. Al . ."Elimination of mother-to-child transmission of hepatitis B virus in Gulf Cooperation Council countries: current status and future prospects.". The American Journal of Tropical Medicine and Hygiene, 110(2024) : 32-35.
AlAteeq M. . ."Long-term immunity against hepatitis B virus after routine immunization among adults visiting primary care centers in Riyadh. Saudi Arabia." Cureus, 14(2022) : e21266.
Al-Faleh F.Z. . ."Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination program. " Journal of Infection, 38(1999) : 167-170.
Al-Faleh F.Z. . ."Integration of hepatitis B vaccine into the expanded program on immunization: the Saudi Arabian experience. " Annals of Saudi Medicine, 13(1993) : 231-236.
Alfaleh F. . ."Long-term protection of hepatitis B vaccine 18 years after vaccination. " Journal of Infection, 57(2008) : 404-409.
Hudu S.A. . ."Antibody and immune memory persistence post infant hepatitis B vaccination." Patient Preference and Adherence. , 7(2013) : 981-986.
Yang Y.T. . ."The prevalence of hepatitis B core antibody in vaccinated Chinese children: a hospital-based study. " Vaccine, 37(2019) : 458-463.
Al-Ajlan A. .2011 ."Prevalence of hepatitis B and C among students of health colleges in Saudi Arabia." Eastern Mediterranean Health Journal. , 17(10) : 759-762.
Lingawi H.S.,Afifi I.K. . ."Seroprotection of hepatitis B vaccine in dental students two decades after infant immunization and the possible need for revaccination.". European Journal of Dentistry, 17(2023) : 143-149.
Mahallawi W. . ."Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.". Annals of Saudi Medicine, 38(2018) : 413-419.
Aljumah A.A. . ."Hepatitis B care pathway in Saudi Arabia: current situation, gaps and actions.". Saudi Journal of Gastroenterology, 25(2019) : 73-80.
Alghamdi I.G. .2023 .". Hepatic Medicine: Evidence and Research, 15 : 233-247.
Madani T.A. . ."Trend in hepatitis B virus incidence during a decade of universal childhood vaccination in Saudi Arabia.". Transactions of the Royal Society of Tropical Medicine and Hygiene, 101(2007) : 278-283.
.2020 .Prevention of Mother-to-Child Transmission of Hepatitis B Virus (HBV): Guidelines on Antiviral Prophylaxis in Pregnancy. , : .
Chang M.H. .1997 ."Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children.". The New England Journal of Medicine, 336(26) : 1855-1859.
Chiang C.J. . ."Association of nationwide hepatitis B vaccination and antiviral therapy programs with end-stage liver disease burden in Taiwan." JAMA Network Open. , 5(2022) : e2222367.
Brierley R. . ."Elimination of viral hepatitis by 2030: ambitious, but achievable.". The Lancet Gastroenterology & Hepatology, 4(2019) : 88-89.
Akbar S.M.F. . ."Elimination of hepatitis by 2030: present realities and future projections." Infectious Diseases and Immunity. , 2(2022) : 3-8.
Abaalkhail F.A. . ."SASLT practice guidelines for the management of hepatitis B.". Saudi Journal of Gastroenterology, 27(2021) : 261-292.
.2020 ."Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years. , : .
Van Damme,P. Damme . ."Long-term protection after hepatitis B vaccine.". The Journal of Infectious Diseases, 214(2016) : 1-3.
Kuhns M.C. . ."Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.". Virology Journal, 16(2019) : 43.
Blanco S. . ."Breakthrough infection by hepatitis B virus in a vaccinated blood donor: an emerging threat for transfusion safety in low-endemic countries?". Journal of Medical Virology, 96(2024) : e29463.
Leong J. . ."Hepatitis B surface antigen escape mutations: indications for initiation of antiviral therapy revisited.". World Journal of Clinical Cases, 4(2016) : 71-75.
Kuijper L. .2024 ."Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection." Frontiers in Immunology. , 15 : 1505719.
Hsu H.Y. . ."Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study. " Hepatology, 61(2015) : 1183-1191.
Hennig B.J. . ."Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. " PLoS One, 3(2008) : e1898.
Bello N. . ."Overview of hepatitis B vaccine nonresponse and associated B cell amnesia: a scoping review. " Pathogens, 13(2024) : 554.
Li Z.K. .2013 ."The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis. " Vaccine, 31(40) : 4355-4361.
Macedo L.C. . ."Association of cytokine genetic polymorphisms with the humoral immune response to recombinant vaccine against HBV in infants. " Journal of Medical Virology, 82(2010) : 929-933.
Crooke S.N. .2019 ."Immunosenescence and human vaccine immune responses.". Immunity & Ageing, 16 : 25.
Alexander M. .2024 ."Pathology of diabetes-induced immune dysfunction.". International Journal of Molecular Sciences, 25(13) : 7105.
Hudu S.A. . ."An overview of hepatitis B virus surface antigen mutant in the Asia Pacific." Current Issues in Molecular Biology. , 16(2014) : 69-77.
Bugya Z. . ."Multiple levels of immunological memory and their association with vaccination. " Vaccines, 9(2021) : 174.
Al-Qahtani A.A. .2020 ."Molecular epidemiology, phylogenetic analysis and genotype distribution of hepatitis B virus in Saudi Arabia: predominance of genotype D1." Infection, Genetics and Evolution. , 77 : 104051.
Araujo N. .2020 ."Comprehensive analysis of clinically significant hepatitis B virus mutations in relation to genotype, subgenotype and geographic region." Frontiers in Microbiology. , 11 : 616023.
Al-Qudari A.Y. . ."Surface gene variants of hepatitis B virus in Saudi patients.". Saudi Journal of Gastroenterology, 22(2016) : 133-138.
Piermatteo L. . ."Unexpected rise in the circulation of complex HBV variants enriched with HBsAg vaccine-escape mutations in HBV genotype D: potential impact on HBsAg detection/quantification and vaccination strategies. " Emerging Microbes & Infections, 12(2023) : 2219347.
Takuissu G.R. . ."Global epidemiology of occult hepatitis B virus infections in blood donors: a systematic review and metaanalysis. " PLoS One, 17(2022) : e0272920.
Lello Di,F. Di .2022 ."Insights into induction of the immune response by the hepatitis B vaccine.". World Journal of Gastroenterology, 28(31) : 4249-4262.
Saitta C. . ."Occult hepatitis B virus infection: an update. " Viruses, 14(2022) : 1504.
Liu H. . ."Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients.". Virology Journal, 21(2024) : 92.
Liu X. .2023 ."Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients". , 1211980 : .
Saran Al,K. Al . ."Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi hemodialysis center". Saudi Journal of Kidney Diseases and Transplantation, 25(2014) : 185-191.
Ali M.J. . ."Immune-escape mutations are prevalent among patients with a coexistence of HBsAg and anti-HBs in a tertiary liver center in the United States". Viruses, 16(2024) : 713.
Konopleva M.V. . ."Recombinant HBsAg of the wildtype and the G145R escape mutant included in the new multivalent vaccine against hepatitis B virus dramatically differ in their effects on leukocytes from healthy donors in vitro". Vaccines, 10(2022) : 235.
Das ,M.K ,Tropical Diseases . ."Temperature integrity and exposure of vaccines to suboptimal temperatures in cold chain devices at different levels in three states in India". Travel Medicine and Vaccines, 6(2020) : 8.
Washizaki A. . ."Neutralization of hepatitis B virus with vaccine-escape mutations by the hepatitis B vaccine with large-HBs antigen". Nature Communications, 13(2022) : 5207.
Alshayea A. .2016 ."Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia". Saudi Medical Journal, 37(10) : 1114-1119.
Im Y.R. .2022 ."Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis". Lancet Gastroenterology & Hepatology, 7(10) : 932-942.
Kwak M.,Kim Y. .2014 ."Occult hepatitis B virus infection". World Journal of Hepatology, 6(12) : 860-869.
Alqahtani J.M. .2014 ."Seroprevalence of hepatitis B and C virus infections among health students and health care workers in the Najran region, southwestern Saudi Arabia: the need for national guidelines for health students". BMC Public Health, 14 : 577.